Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?
(MedPage Today) -- VIENNA -- Researchers trained an artificial intelligence (AI) model to determine if a patient with hepatocellular carcinoma (HCC) will respond to standard treatment with atezolizumab (Tecentriq) plus bevacizumab (Avastin)...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Urology & Nephrology